lung
transplant
viabl
treatment
option
endstag
lung
diseas
common
indic
lung
transplant
chronic
obstruct
pulmonari
diseas
copd
idiopath
pulmonari
fibrosi
cystic
fibrosi
antitrypsin
defici
pulmonari
arteri
hypertens
pah
less
common
indic
includ
endstag
sarcoidosi
lymphangioleiomyomatosi
lam
pulmonari
langerhan
cell
histiocytosisgranulomatosi
plchg
interstiti
lung
diseas
either
singl
bilater
lung
transplant
perform
bilater
transplant
requir
patient
suppur
lung
diseas
includ
cystic
fibrosi
patient
pah
suitabl
outcom
may
achiev
singl
lung
transplant
diagnos
trend
recent
year
use
bilater
transplant
larg
relat
suggest
better
longterm
surviv
seen
registri
data
specif
accord
intern
societi
heart
lung
transplant
ishlt
registri
report
median
surviv
adult
recipi
year
bilater
lung
recipi
appear
better
median
surviv
singl
lung
recipi
versu
year
respect
overal
surviv
lung
transplant
improv
due
refin
surgic
techniqu
improv
organ
procur
preserv
techniqu
advanc
medic
manag
immunosuppress
common
caus
mortal
first
day
lung
transplant
primari
graft
dysfunct
infect
common
caus
mortal
first
month
chronic
reject
thereaft
complic
lung
transplant
common
may
nonspecif
clinic
radiolog
manifest
addit
frequent
sever
complic
may
coexist
complic
present
order
reduc
mortal
morbid
among
lung
transplant
recipi
import
recogn
complic
accur
time
time
point
complic
occur
rel
date
transplant
crucial
formul
differenti
diagnosi
recogn
accur
chapter
describ
radiolog
manifest
variou
pulmonari
complic
occur
lung
transplant
complic
classifi
chronolog
group
base
time
transplant
immedi
h
earli
h
week
intermedi
day
month
primari
late
month
secondari
late
month
tabl
size
mismatch
donor
lung
recipi
thorac
caviti
may
result
mechan
complic
center
accept
size
differ
rang
donor
lung
larg
recipi
thorac
caviti
atelectasi
impair
ventil
may
result
atelectasi
may
evid
immedi
postop
radiograph
hand
small
allograft
lung
use
singl
lung
transplant
emphysema
hyperexpand
nativ
lung
may
compress
allograft
result
restrict
pulmonari
function
fig
b
nativ
lung
volum
reduct
surgeri
perform
time
transplant
may
help
prevent
complic
lung
torsion
rare
seriou
complic
occur
due
discrep
size
recipi
enlarg
thorac
caviti
donor
small
lung
imag
show
torsion
hilar
structur
includ
vasculatur
airway
lead
collaps
lobe
entir
lung
due
airway
compromis
expans
consolid
lobe
due
hemorrhag
infarct
lung
torsion
suspect
immedi
surgeri
indic
avoid
death
parenchym
necrosi
hyperacut
reject
caus
presenc
preform
antibodi
donor
organspecif
human
leukocyt
antigen
hla
abo
antigen
abo
match
improv
antibodi
detect
crossmatch
techniqu
made
hyperacut
reject
rare
lung
transplant
present
lead
acut
alveolar
damag
result
graft
dysfunct
within
minut
hour
graft
reperfus
chest
radiograph
hyperacut
reject
manifest
diffus
homogen
opacif
entir
allograft
manag
option
includ
aggress
immunosuppress
plasmapheresi
urgent
retransplant
primari
graft
dysfunct
form
noncardiogen
pulmonari
edema
usual
occur
postop
day
peak
sever
day
gener
improv
day
diagnos
exclud
left
heart
failur
fluid
overload
infect
acut
transplant
reject
pathogenesi
primari
graft
dysfunct
multifactori
includ
interrupt
lymphat
bronchial
circul
donor
organ
ischemia
surgic
trauma
denerv
donor
lung
decreas
surfact
product
chest
radiographi
ct
manifest
nonspecif
includ
perihilar
lower
lobe
predomin
groundglass
opac
andor
consolid
interlobular
septal
thicken
peribronchi
airspac
opac
fig
pleural
complic
pleural
effus
hemothorax
pneumothorax
patient
transplant
exist
pleural
abnorm
lung
transplant
predispos
pleural
complic
instanc
pleural
infect
inflamm
result
endstag
lung
diseas
lung
transplant
requir
cystic
fibrosi
invas
procedur
requir
diagnos
wedg
biopsi
treat
pleurodesi
pleural
drain
pneumothorax
pleural
effus
endstag
lung
diseas
may
result
pleural
abnorm
pneumothorax
common
pleural
complic
fig
b
airway
anastomot
complic
suspect
pneumothorax
persist
enlarg
earli
postop
period
day
transplant
pleural
effus
also
common
complic
secondari
increas
capillari
permeabl
impair
lymphat
drainag
allograft
lung
earli
postop
period
fig
b
pleural
fluid
immedi
postop
period
often
hemorrhag
becom
progress
less
hemorrhag
day
pleural
effus
usual
resolv
week
persist
enlarg
pleural
effus
rais
suspicion
empyema
left
heart
failur
hemothorax
usual
result
surgic
complic
fig
b
persist
air
leak
empyema
hemothorax
associ
increas
mortal
promptli
recogn
manag
acut
reject
usual
occur
second
postop
week
classic
caus
cellmedi
immun
respons
approxim
acut
reject
occur
first
month
patient
least
one
episod
acut
reject
first
postop
year
repeat
episod
acut
reject
consid
risk
factor
develop
chronic
reject
present
radiograph
manifest
nonspecif
similar
primari
graft
dysfunct
includ
groundglass
opac
consolid
interlobular
septal
thicken
pleural
effus
fig
b
b
radiograph
improv
within
h
administr
intraven
corticosteroid
favor
diagnosi
acut
reject
airway
anastomot
complic
includ
bronchial
dehisc
bronchial
stenosi
bronchomalacia
report
incid
airway
complic
approxim
decreas
airway
complic
rate
due
refin
surgic
techniqu
improv
immunosuppress
donor
organ
preserv
techniqu
import
factor
predispos
airway
complic
donor
bronchu
ischemia
due
disrupt
nativ
bronchial
circul
recurr
infect
reject
contribut
factor
bronchial
dehisc
usual
occur
first
week
transplant
affect
patient
ct
usual
show
extralumin
foci
air
perianastomot
region
occasion
bronchial
defect
visual
fig
b
b
indirect
sign
includ
persist
enlarg
air
leak
pneumothorax
pneumomediastinum
bronchial
dehisc
may
resolv
spontan
progress
bronchial
stenosi
bronchial
stenosi
bronchomalacia
late
complic
usual
occur
least
month
transplant
bronchial
stenosi
occur
subject
usual
seen
anastomot
site
distal
ct
show
bronchial
irregular
focal
stenosi
fig
b
manag
includ
resect
granul
tissu
balloon
dilat
without
stent
bronchomalacia
transient
airway
narrow
diagnos
bronchoscopi
ct
inspiratori
expiratori
ct
imag
invalu
diagnosi
bronchomalacia
fig
b
diagnosi
suggest
liber
conserv
dynam
narrow
airway
lunat
shape
airway
expir
vascular
anastomot
complic
uncommon
pulmonari
arteri
stenosi
common
pulmonari
vein
stenosi
occur
earli
late
postop
period
contrastenhanc
ct
angiogram
best
avail
noninvas
modal
assess
narrow
occlus
anastomot
site
may
caus
pulmonari
infarct
readili
due
absenc
bronchial
arteri
circul
earli
postop
period
treatment
option
includ
angioplasti
stent
infect
common
complic
lead
caus
morbid
mortal
lung
transplant
patient
increas
risk
infect
immunosuppress
impair
mucociliari
clearanc
absenc
cough
reflex
disrupt
lymphat
drainag
direct
commun
allograft
atmospher
infecti
risk
vari
base
factor
includ
time
elaps
sinc
transplant
bacteri
infect
common
caus
pneumonia
incid
highest
first
week
lung
transplant
gramneg
organ
klebsiella
speci
pseudomona
aeruginosa
common
caus
agent
infect
gramposit
organ
includ
staphylococcu
aureu
also
observ
first
postop
month
recipi
develop
bacteri
pneumonia
imag
featur
similar
nontranspl
popul
includ
lobar
multifoc
consolid
groundglass
opac
nodul
pleural
effus
fig
b
fungal
infect
caus
aspergillu
less
commonli
candida
speci
pneumocysti
pneumonia
uncommon
day
routin
chemoprophylaxi
fungal
infect
occur
time
usual
peak
day
transplant
less
common
carri
higher
mortal
compar
bacteri
viral
infect
pattern
fungal
infect
includ
angioinvas
pulmonari
infect
ulcer
tracheobronch
bronchial
anastomosi
infect
ct
angioinvas
fungal
infect
show
illdefin
nodul
masslik
consolid
surround
groundglass
opac
halo
sign
indic
hemorrhag
fig
b
ct
tracheobronch
show
diffus
central
airway
wall
thicken
surround
mediastin
fat
strand
bronchial
anastomosi
infect
caus
bronchial
dehisc
show
small
foci
extralumin
air
adjac
airway
cytomegaloviru
cmv
common
opportunist
infect
second
common
caus
pneumonia
lung
transplant
patient
cmv
pneumonia
usual
occur
month
transplant
cmvseroneg
recipi
receiv
cmvseroposit
donor
lung
increas
risk
develop
primari
infect
ct
show
vari
pattern
includ
groundglass
opac
centrilobular
nodul
treeinbud
pattern
consolid
interlobular
septal
thicken
fig
b
addit
cmv
commun
acquir
virus
adenoviru
respiratori
syncyti
viru
rsv
influenza
parainfluenza
virus
may
infect
lung
transplant
recipi
viral
infect
predispos
lung
transplant
recipi
oblit
bronchiol
manifest
chronic
reject
chronic
reject
clinicopatholog
syndrom
often
character
oblit
bronchiol
affect
lung
transplant
recipi
year
term
bronchiol
obliteran
syndrom
bo
use
describ
clinic
situat
major
factor
limit
longterm
surviv
lung
transplant
recipi
usual
occur
month
transplant
risk
factor
includ
prior
episod
recurr
acut
reject
infect
particularli
cmv
pneumonia
oblit
bronchiol
common
histolog
pattern
seen
bo
manifest
eosinophil
hyalin
fibrosi
respiratori
bronchiolar
wall
lumin
occlus
due
patchi
distribut
diseas
transbronchi
biopsi
may
neg
case
diagnosi
made
clinic
basi
otherwis
unexplain
persist
decreas
indic
small
airway
diseas
pulmonari
function
test
classic
show
obstruct
pattern
combin
obstruct
restrict
may
seen
highresolut
ct
show
bronchial
wall
thicken
bronchiectasi
heterogen
area
hyperluc
dark
interspers
adjac
normal
lung
parenchyma
mosaic
attenu
accentu
exhal
imag
thu
import
obtain
pair
inspiratori
expiratori
hrct
imag
chronic
reject
suspect
clinic
expir
hrct
normal
lung
parenchyma
becom
greyer
hyperluc
patholog
lung
remain
dark
indic
air
trap
fig
b
b
thu
differenti
normal
abnorm
lung
becom
pronounc
expir
ct
organ
pneumonia
pattern
similar
patient
cryptogen
organ
pneumonia
occur
patient
lung
transplant
may
associ
acut
chronic
reject
may
repres
infect
character
presenc
inflammatori
granul
tissu
within
alveoli
alveolar
sac
duct
respond
rapidli
highdos
corticosteroid
bronchoscopi
often
done
exclud
infect
start
highdos
corticosteroid
ct
show
peripher
peribronchovascular
perilobular
consolid
fig
frequent
peripher
arclik
consolid
central
groundglass
opac
revers
haloatol
sign
seen
posttranspl
lymphoprolif
disord
spectrum
diseas
vari
benign
lymphoid
hyperplasia
highgrad
lymphoma
typic
manifest
within
year
transplant
seen
month
sever
year
transplant
ptld
risk
increas
significantli
epsteinbarr
viru
ebv
seroneg
recipi
receiv
lung
seroposit
donor
major
risk
factor
augment
immunosuppress
incid
vari
year
transplant
common
lung
transplant
solid
organ
transplant
major
case
ptld
b
cell
origin
associ
ebv
primari
infect
much
smaller
proport
ptld
cell
origin
hodgkin
type
rare
plasma
cell
type
multipl
myeloma
categori
like
ebvneg
ebvassoci
ptld
present
earli
within
year
usual
benign
cours
intrathorac
wherea
ebvneg
ptld
present
late
median
onset
month
posttranspl
gener
aggress
extrathorac
earli
diseas
respond
antivir
therapi
reduct
immunosuppress
late
diseas
gener
requir
chemotherapi
radiat
therapi
ct
show
solitari
multipl
nodul
peripher
basal
predomin
distribut
fig
b
b
masslik
consolid
mediastin
hilar
lymphadenopathi
also
commonli
seen
rare
interlobular
septal
thicken
seen
pleural
chest
wall
mass
without
pleural
effus
andor
pericardi
effus
describ
biopsi
often
need
differenti
ptld
infect
upper
lobe
fibrosi
uncommon
occur
year
transplant
exact
caus
unknown
describ
compon
chronic
allograft
dysfunct
clad
demonstr
restrict
physiolog
hypothes
variant
chronic
reject
clinic
patient
present
restrict
allograft
syndrom
ra
mark
restrict
pulmonari
function
test
often
demonstr
aggress
treatmentrefractori
cours
compar
oblit
bronchiol
ct
show
interlobular
septal
thicken
traction
bronchiectasi
volum
loss
architectur
distort
fig
b
recurr
primari
diseas
transplant
lung
uncommon
report
incid
sarcoidosi
common
diseas
recur
transplant
report
approxim
patient
diseas
recur
includ
lymphangioleiomyomatosi
lam
pulmonari
langerhan
cell
histiocytosi
plch
pulmonari
alveolar
proteinosi
pap
multifoc
adenocarcinoma
previous
bronchioloalveolar
carcinoma
recurr
primari
diseas
report
earli
week
late
year
transplant
radiolog
manifest
similar
primari
diseas
bronchoscopi
transbronchi
biopsi
frequent
perform
lung
transplant
aid
diagnosi
variou
aforement
complic
transbronchi
biopsi
lead
variou
complic
includ
pneumothorax
hemothorax
pulmonari
hemorrhag
solid
cavitari
nodul
surround
groundglass
opac
may
incident
find
allograft
month
result
transbronchi
biopsi
correspond
locat
thu
find
must
interpret
caution
confus
fungal
infect
tempor
relationship
biopsi
locat
nodul
known
biopsi
site
help
distinguish
nodul
infect
wide
spectrum
complic
overlap
radiolog
find
may
occur
lung
transplant
familiar
radiolog
appear
complic
correl
clinic
manifest
time
cours
sinc
transplant
help
manag
patient
threshold
perform
ct
low
detect
infect
immunocompromis
popul
earli
stage
ct
protocol
tailor
suspect
complic
perform
inspir
expir
ct
chronic
allograft
dysfunct
suspect
perform
ct
angiogram
vascular
complic
suspect
accur
tailor
ct
protocol
increas
yield
imag
use
appropri
retriev
specimenssampl
abnorm
airway
pulmonari
parenchyma
identifi
specif
patholog
followup
imag
essenti
guid
patient
clinic
cours
pulmonari
function
test
